Results of a study investigating ofatumumab combined with chemotherapy for first line treatment of CLL.
Home / Resource Library / Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis